Info@ThinkPinkRocks.com

Patient with severe Alzheimer’s shows promising benefits during treatment with Bryostatin drug

Researchers at the Blanchette Rockefeller Neurosciences Institute and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, “PSEN1 Variant in a Family with Atypical AD.” An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1.

Taken from:
Patient with severe Alzheimer’s shows promising benefits during treatment with Bryostatin drug

Share
  1. Hello admin, i must say you have very interesting posts here.
    Your blog can go viral. You need initial traffic boost only.
    How to get it? Search for; make your content go viral Wrastain’s tools

Leave a Reply

Solve : *
7 + 30 =